Avantor Inc (AVTR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Avantor Inc stock (AVTR) is currently trading at $7.69. Avantor Inc PS ratio (Price-to-Sales) is 0.81. Analyst consensus price target for AVTR is $10.86. WallStSmart rates AVTR as Sell.
- AVTR PE ratio analysis and historical PE chart
- AVTR PS ratio (Price-to-Sales) history and trend
- AVTR intrinsic value — DCF, Graham Number, EPV models
- AVTR stock price prediction 2025 2026 2027 2028 2029 2030
- AVTR fair value vs current price
- AVTR insider transactions and insider buying
- Is AVTR undervalued or overvalued?
- Avantor Inc financial analysis — revenue, earnings, cash flow
- AVTR Piotroski F-Score and Altman Z-Score
- AVTR analyst price target and Smart Rating
Avantor Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Avantor Inc (AVTR) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and revenue growth. Mixed signals suggest waiting for clearer direction before acting.
Avantor Inc (AVTR) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
103.22% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Avantor Inc (AVTR) Areas to Watch (5)
Company is destroying shareholder value
Revenue declining -1.40%, a shrinking business
Earnings declining -89.40%, profits shrinking
Company is losing money with a negative profit margin
Thin operating margins with cost pressures present
Avantor Inc (AVTR) Detailed Analysis Report
Overall Assessment
This company scores 42/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.3/10) while 5 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.81), Price/Book (0.92) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, EPS Growth. Growth concerns include Revenue Growth at -1.40%, EPS Growth at -89.40%, which may limit upside. Profitability pressure is visible in Return on Equity at -9.20%, Operating Margin at 10.20%, Profit Margin at -8.09%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -9.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AVTR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AVTR's Price-to-Sales ratio of 0.81x trades at a deep discount to its historical average of 2x (3th percentile). The current valuation is 78% below its historical high of 3.7x set in Sep 2021, and 7% above its historical low of 0.75x in Sep 2019. Over the past 12 months, the PS ratio has compressed from ~1.6x as trailing revenue scaled faster than the stock price.
Compare AVTR with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Avantor Inc (AVTR) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Avantor Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 6.6B with 140% decline year-over-year. The company is currently unprofitable, posting a -8.1% profit margin.
Key Findings
Generating 117M in free cash flow and 153M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 140% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -8.1% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Debt management: total debt of 3.9B is significantly higher than cash (365M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Avantor Inc.
Bottom Line
Avantor Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(33 last 3 months)
| Insider | Type | Shares |
|---|---|---|
MEHRA, SANJEEV K Director | Buy | +125,000 |
| Insider | Type | Shares |
|---|---|---|
SUMME, GREGORY L Director | Buy | +100,000 |
| Insider | Type | Shares |
|---|---|---|
DINGEMANS, SIMON Director | Buy | +6,225 |
Data sourced from SEC Form 4 filings
Last updated: 8:23:45 AM
About Avantor Inc(AVTR)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Avantor, Inc. provides products and services to clients in the biopharmaceutical, healthcare, education and government, advanced technologies and applied materials industries in America, Europe, Asia, the Middle East and Africa. The company is headquartered in Radnor, Pennsylvania.